TNYA
Income statement / Annual
Last year (2024), Tenaya Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Tenaya Therapeutics, Inc.'s net income was -$111.13 M.
See Tenaya Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$8.47 M
|
$8.69 M
|
$8.71 M
|
$4.03 M
|
$2.48 M
|
$1.99 M
|
| Gross Profit |
-$8.47 M
|
-$8.69 M
|
-$8.71 M
|
-$4.03 M
|
-$2.48 M
|
-$1.99 M
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$86.74 M
|
$98.04 M
|
$94.54 M
|
$54.39 M
|
$31.10 M
|
$23.15 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.56 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$20.74 M
|
$24.47 M
|
$22.37 M
|
$14.39 M
|
$5.33 M
|
$4.56 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.03 M
|
| Operating Expenses |
$107.48 M
|
$122.51 M
|
$116.91 M
|
$68.78 M
|
$36.43 M
|
$27.71 M
|
| Cost And Expenses |
$115.95 M
|
$131.19 M
|
$125.62 M
|
$72.81 M
|
$38.91 M
|
$27.71 M
|
| Interest Income |
$4.74 M
|
$7.06 M
|
$1.95 M
|
$108.00 K
|
$87.00 K
|
$453.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$8.47 M
|
$8.69 M
|
$8.71 M
|
$4.03 M
|
$2.48 M
|
$1.99 M
|
| EBITDA |
-$102.66 M |
-$115.40 M |
-$114.95 M |
-$68.70 M |
-$35.91 M |
-$25.72 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$4.82 M
|
$7.11 M
|
$1.96 M
|
$85.00 K
|
$517.00 K
|
$1.48 M
|
| Income Before Tax |
-$111.13 M
|
-$124.08 M
|
-$123.67 M
|
-$72.72 M
|
-$38.40 M
|
-$26.23 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$111.13 M
|
-$124.08 M
|
-$123.67 M
|
-$72.72 M
|
-$38.40 M
|
-$25.78 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.31 |
-1.68 |
-2.76 |
-1.69 |
-0.93 |
-0.95 |
| EPS Diluted |
-1.31 |
-1.68 |
-2.76 |
-1.69 |
-0.93 |
-0.95 |
| Weighted Average Shares Out |
$84.82 M
|
$73.79 M
|
$44.82 M
|
$41.29 M
|
$41.12 M
|
$27.20 M
|
| Weighted Average Shares Out Diluted |
$84.82 M
|
$73.79 M
|
$44.82 M
|
$41.29 M
|
$41.12 M
|
$27.20 M
|
| Link |
|
|
|
|
|
|
